Filing Flows › Omnicell (OMCL) › Capital expenditures
Omnicell (OMCL) capital expenditures by quarter
Omnicell's capital expenditures were $11.4M in Q3 2026 (third quarter 2026), +27% from Q2 2026. Over the last 7 quarters it ranged from $7.7M (Q4 2025) to $12.4M (Q1 2026).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $11.4M | +27% | +17% |
| Q2 2026 | $8.9M | -28% | -24% |
| Q1 2026 | $12.4M | +61% | +11% |
| Q4 2025 | $7.7M | -21% | — |
| Q3 2025 | $9.8M | -17% | — |
| Q2 2025 | $11.8M | +5% | — |
| Q1 2025 | $11.2M | — | — |
Q3 2026 at a glance
Omnicell, Q3 2026: revenue $308M (-0.9% year over year), operating margin 4.9%, net earnings $11.0M, operating cash flow $33.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Omnicell's capital expenditures?
Omnicell's capital expenditures were $11.4M in Q3 2026 (third quarter 2026), +27% from Q2 2026.
How has Omnicell's capital expenditures changed?
Over the last 7 quarters it ranged from $7.7M (Q4 2025) to $12.4M (Q1 2026).